It is a pharma private limited company based in Pune, Maharashtra, India, established in 2015.
2015 | Pune, Maharashtra, India | ActiveShellcure Pharmaceuticals Private Limited, a active private limited company, was established on 06 January 2015 in Pune, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U85100PN2015PTC153620. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sushant Balkrishna Navandhar (Additional Director), Dhairyashil Uttamrao Shinde (Director), Vikram Uttam Shinde (Director). Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Fl No C 204, Sukhanand Complex S No 225/5A, Hadapsar, Pune, Maharashtra, 411016.
U85100PN2015PTC153620
153620
06 January 2015
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Shellcure Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sushant Balkrishna Navandhar | Additional Director | 30 Jun 2020 | Current |
| Dhairyashil Uttamrao Shinde | Director | 06 Jan 2015 | Current |
| Vikram Uttam Shinde | Director | 06 Jan 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shellcure Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 6.94% decrease. The company also saw a substantial improvement in profitability, with a 72.11% increase in profit. The company's net worth dipped by a decrease of 3.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Shellcure Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shellcure Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shellcure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shellcure Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shellcure Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was documented.
Sushant Balkrishna Navandhar was appointed as a Additional Director was appointed as a Additional Director on 30 Jun 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
Progress on Shellcure Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Pune. was documented.
Progress on Dhairyashil Uttamrao Shinde was appointed as a Director was appointed as a Director on 06 Jan 2015 & has been associated with this company since 10 years 11 months . was documented.
Progress on Vikram Uttam Shinde was appointed as a Director was appointed as a Director on 06 Jan 2015 & has been associated with this company since 10 years 11 months . was documented.
Progress on Shellcure Pharmaceuticals Private Limited was registered on 06 Jan 2015 with Roc Pune & aged 10 years 11 months as per MCA records. was documented.
The CIN of Shellcure Pharmaceuticals Private Limited is U85100PN2015PTC153620.
Shellcure Pharmaceuticals Private Limited is headquartered at Fl No C 204, Sukhanand Complex S No 225/5A, Hadapsar, Pune, Maharashtra, 411016.
Shellcure Pharmaceuticals Private Limited was incorporated on 06 January 2015.
The current directors of Shellcure Pharmaceuticals Private Limited are
The primary industry of Shellcure Pharmaceuticals Private Limited is Pharma.
Shellcure Pharmaceuticals Private Limited is unlisted.
The authorized capital of Shellcure Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Shellcure Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX